𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system

✍ Scribed by Andreas Stahl; Barbara M. Mueller


Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
146 KB
Volume
71
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Tumor cell migration and invasion require complex interactions between tumor cells and the surrounding extracellular matrix. These interactions are modified by cell adhesion receptors, as well as by proteolytic enzymes and their receptors. Here, we study the influence of the protease urokinasetype plasminogen activator (uPA) and its receptor (uPAR) on melanoma cell adhesion to, and migration on, the extracellular matrix protein vitronectin (VN). Cell adhesion to VN, but not to type I collagen, is significantly enhanced in the presence of either uPA or its amino-terminal fragment (ATF). Soluble uPAR can inhibit this effect, indicating that uPA/ uPAR on melanoma cells can function as a VN receptor. In the absence of bivalent cations, uPA/uPAR can promote cell attachment on VN, but not cell spreading, suggesting that the glycosylphosphatidylinositol (GPI)-anchored uPAR alone is unable to organize the cytoskeleton. Chemotactic melanoma cell migration on a uniform VN matrix is inhibited by uPA and ATF, implying that cell motility decreases when uPA/uPAR acts as a VN receptor. In contrast, plasminogen activator inhibitor 1 (PAI-1) can stimulate melanoma cell migration on VN, presumably by inhibiting uPA/uPAR-mediated cell adhesion to VN and thereby releasing the inhibition of cell migration induced by uPA. Together, our data implicate components of the plasminogen activation system in the direct regulation of cell adhesion and migration, thereby modulating the behavior of malignant tumor cells.


πŸ“œ SIMILAR VOLUMES


Plasminogen activator inhibitor-1 regula
✍ Gary Deng; Scott A. Curriden; Geng Hu; Ralf-Peter Czekay; David J. Loskutoff πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 247 KB

## Abstract Plasminogen activator inhibitor‐1 (PAI‐1) binds to the somatomedin B (SMB) domain of vitronectin. It inhibits the adhesion of U937 cells to vitronectin by competing with the urokinase receptor (uPAR; CD87) on these cells for binding to the same domain. Although the inhibitor also blocks

Fibrinolytic system of cultured endothel
✍ David J. Loskutoff; Dr. Tor Ny; Michael Sawdey; Daniel Lawrence πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 545 KB

Cultured bovine aortic endothelial cells have a relatively complex fibrinolytic system that is responsive to both the physiological state of the cell itself and to a variety of agents added to the culture medium. The fibrinolytic activity of these cells results from the production of both urokinase-

Induction of the urokinase plasminogen a
✍ Kurt Strand; Jacqueline Murray; Salim Aziz; Atsushi Ishida; Salman Rahman; Yatin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

Oncostatin M (OSM) is an inflammatory cytokine produced by activated macrophages and T-lymphocytes. We have previously demonstrated that OSM-induced endothelial cell migration, unlike endothelial cell proliferation and spindle formation, is independent of basic fibroblast growth factor expression (W

Co-cultivation of tumorigenic mouse mela
✍ David Kyner; Judith Christman; George Acs; Selma Silagi; Elizabeth W. Newcomb; S πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 1012 KB

Clone B559 mouse melanoma cells are highly tumorigenic and produce plasminogen activator. Cells of clone C3471, a line obtained by continued growth of B559 cells in medium containing 5-bromodeoxyuridine (1 pg/ml), have no plasminogen activator and are non-tumorigenic. When B559 cells are co-cultivat